A COMPARISON OF INTRAOCULAR-PRESSURE ELEVATING ACTIVITY OF LOTEPREDNOL ETABONATE AND DEXAMETHASONE IN RABBITS

被引:35
作者
BODOR, N
BODOR, N
WU, WM
机构
[1] Center for Drug Discovery, J. Hillis Miller Health Center, College of Pharmacy, University of Florida, Gainesville, FL 32610
关键词
D O I
10.3109/02713689209001808
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
A "Soft" corticosteroid, loteprednol etabonate I, designed based on the "inactive metabolite" concept can be used as a safe ophthalmic anti-inflammatory drug. By design, the metabolism of I follows a predicted biotransformation pathway, thus unwanted systemic side effects are avoided. Local side effects are also reduced. Accordingly, in a cross-over study I did not elevate the intraocular pressure (IOP) in rabbits, as opposed to dexamethasone.
引用
收藏
页码:525 / 530
页数:6
相关论文
共 20 条
[1]  
[Anonymous], ADV DRUG RES
[4]   SOFT DRUGS - PRINCIPLES AND METHODS FOR THE DESIGN OF SAFE DRUGS [J].
BODOR, N .
MEDICINAL RESEARCH REVIEWS, 1984, 4 (04) :449-469
[5]   EFFECT OF A NOVEL SOFT STEROID ON THE WOUND-HEALING OF RABBIT CORNEA [J].
BODOR, N ;
VARGA, M .
EXPERIMENTAL EYE RESEARCH, 1990, 50 (02) :183-187
[6]  
Bodor N, 1991, US Patent, Patent No. 4996335
[7]  
BODOR N, 1984, CHEMTECH JAN, P28
[8]  
BODOR N, 1988, TOPICAL CORTICOSTERO, P13
[9]   NOVEL SOFT STEROIDS - EFFECTS ON CELL-GROWTH INVITRO AND ON WOUND-HEALING IN THE MOUSE [J].
BODOR, NS ;
KISSBURIS, ST ;
BURIS, L .
STEROIDS, 1991, 56 (08) :434-439
[10]   SOFT DRUGS .10. BLANCHING ACTIVITY AND RECEPTOR-BINDING AFFINITY OF A NEW TYPE OF GLUCOCORTICOID - LOTEPREDNOL ETABONATE [J].
DRUZGALA, P ;
HOCHHAUS, G ;
BODOR, N .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 38 (02) :149-154